Howl Bio
Hauul Bio is dedicated to realizing corporate values for the balance of human health and happiness. They focus on innovative next-generation cell therapy platforms, developing technologies for high-sensitivity, high-efficacy antibodies, and recombinant fusion protein technologies. Their mission is to improve cancer treatment and promote sustainable health recovery through advanced biotechnologies.
Industries
Nr. of Employees
small (1-50)
Products
Non-viral recombinant CAR protein cell therapy
Cell therapy approach that uses independently expressed, purified recombinant CAR fusion proteins introduced into immune cells without viral vectors to provide antigen-specific activity.
Modular scFv-based non-viral cell therapy
Modular therapy architecture where scFv antibody fusion modules are manufactured and then bound to immune cells to provide flexible, rapid targeting of different antigens.
Cell surface-engineered cell therapy with ADC integration
Therapies that introduce functional recombinant fusion proteins to immune cell surfaces and apply antibody-drug conjugates to produce combined chemotherapy and immunotherapy effects, with potential for tumor-specific ADC selection.
Antibody discovery and production services
End-to-end services for generating diagnostic and therapeutic antibodies, including library construction, screening and production workflows.
Non-viral recombinant CAR protein cell therapy
Cell therapy approach that uses independently expressed, purified recombinant CAR fusion proteins introduced into immune cells without viral vectors to provide antigen-specific activity.
Modular scFv-based non-viral cell therapy
Modular therapy architecture where scFv antibody fusion modules are manufactured and then bound to immune cells to provide flexible, rapid targeting of different antigens.
Cell surface-engineered cell therapy with ADC integration
Therapies that introduce functional recombinant fusion proteins to immune cell surfaces and apply antibody-drug conjugates to produce combined chemotherapy and immunotherapy effects, with potential for tumor-specific ADC selection.
Antibody discovery and production services
End-to-end services for generating diagnostic and therapeutic antibodies, including library construction, screening and production workflows.
Expertise Areas
- Cell therapy platform development
- Antibody discovery and engineering
- Recombinant fusion protein engineering
- Non-viral immune cell modification
Key Technologies
- Recombinant fusion protein engineering
- scFv (single-chain variable fragment) antibody modules
- Non-viral protein-based delivery to immune cells
- Antibody library generation